Northwest Biotherapeutics (OTCMKTS: NWBO) is now a risk-off biotech trading at a significant discount; in a “sell the news” market, there are...
Cytokinetics (NASDAQ:CYTK) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a note issued to investors on Tuesday....